Next‐day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double‐blind study in healthy elderly subjects

Abstract

A single oral bedtime dose of gaboxadol 10 mg did not have next-day residual effects in healthy elderly subjects, as measured by a range of pharmacodynamic assessments, in contrast to the clear impairments produced by flurazepam 30 mg.